Vivek Rao, MD, PhD, Mehmet C. Oz, MD, Margaret A

Slides:

Advertisements

Similar presentations

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.

Advertisements

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Manuel J. Antunes, MD, PhD, DSc

Susanna L. Matsen, MD, Bruce A. Perler, MD, MBA, David C

Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding Liza.

Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A

Kathy J. Jenkins, MD, MPH, Kimberlee Gauvreau, ScD, Jane W

The RECOVER I: A multicenter prospective study of Impella 5

Association of device surface and biomaterials with immunologic sensitization after mechanical support Isaac George, MD, Patrick Colley, BS, Mark J.

New anticoagulant coatings and hemostasis assessment tools to avoid complications with pediatric left ventricular assist devices Daniel C. Leslie, PhD,

Katharine A. Catanese, MSN, Daniel J. Goldstein, MD, Deborah L

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Skinning the cat: Another wrinkle for T-tube insertion

Go on-pump or off-pump in diabetic patients?

Resuscitation practices in cardiac surgery

Ventricular assist device programs: design and function

The lord of the rings Antonio Miceli, MD, PhD

Conduit conundrum: If not two, why three?

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different Margaret A. Olsen,

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan,

Support Your Specialty

Surgical management of valvular disease in patients requiring left ventricular assist device support Vivek Rao, MD, PhD, James P Slater, MD, Niloo M.

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Transcatheter aortic valve replacement in intermediate-risk patients

It's not “just a shunt” but sometimes it should be…

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery Torsten Doenst, MD, PhD,

Improved outcomes in coronary artery bypass grafting with beating-heart techniques Michael Mack, MD, Donna Bachand, RN, PhD, Tea Acuff, MD, James Edgerton,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Nilto Carias de Oliveira, MD, Tirone E

Commentary: Faster recovery after complex neonatal cardiac surgery

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Mark K. Ferguson, MD, Amy E. Durkin, MS, PA-C

S. Martens, MD, M. Dietrich, MD, M. Doss, MD, G

Daniel T. Engelman, MD, FACS, Michael J. Germain, MD

Attachment disorder in thoracoabdominal surgery

The Ross procedure: Time to reevaluate the guidelines

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Constantine L. Athanasuleas, MD, FACC

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tai Ji: The law of inflammatory response

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

The effect of ischemic time on survival after heart transplantation varies by donor age: An analysis of the United Network for Organ Sharing database

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Cerebrovascular accidents in patients with a ventricular assist device

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Building a clinical program in a single institution

“The more things change…”: The challenges ahead

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

More than vital: Who bears the burden?

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Did you like Terminator 3 better than Terminator 2

A good chimney requires a good sweep

How do we follow up our patients

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

Supraclavicular reoperation for neurogenic thoracic outlet syndrome

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Presentation transcript:

Revised screening scale to predict survival after insertion of a left ventricular assist device Vivek Rao, MD, PhD, Mehmet C. Oz, MD, Margaret A. Flannery, FNP, Katharine A. Catanese, RN, Michael Argenziano, MD, Yoshifumi Naka, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 125, Issue 4, Pages 855-862 (April 2003) DOI: 10.1067/mtc.2003.111 Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Relationship between operative mortality and risk factor summation score. Both the old score and the new score successfully predicted risk after LVAD insertion. In both scales a score of greater than 5 is associated with high mortality. The Journal of Thoracic and Cardiovascular Surgery 2003 125, 855-862DOI: (10.1067/mtc.2003.111) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Discrimination between high and low risk (score >5) for mortality after LVAD insertion. Although both scales successfully predicted risk, the new scale improved discrimination. The Journal of Thoracic and Cardiovascular Surgery 2003 125, 855-862DOI: (10.1067/mtc.2003.111) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

Fig. 3 ROC curves for the old (left) and new (right) risk factor summation scores. Both scores display adequate statistical accuracy, with slightly better accuracy in the new score (area under the ROC curve, c = 0.77 vs 0.73). The Journal of Thoracic and Cardiovascular Surgery 2003 125, 855-862DOI: (10.1067/mtc.2003.111) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions

Fig. 4 The relation between observed and predicted mortality by using the old (top) and new (bottom) scales. The correlation between observed and predicted values was excellent in the new score (r = 0.87), with the slope of the linear regression line close to 1 and a y-intercept close to 0, suggesting accurate predictive ability. In the old score correlation between observed and predicted values was excellent (r = 0.88), but the slope of the linear regression line was significantly greater than 1 (P <.01), and the y-intercept was significantly less than 0 (P <.001). Thus the score overpredicted mortality in patients at low risk (predicted mortality of <30%) and underpredicted mortality in patients with predicted mortalities of greater than 30%. The Journal of Thoracic and Cardiovascular Surgery 2003 125, 855-862DOI: (10.1067/mtc.2003.111) Copyright © 2003 American Association for Thoracic Surgery Terms and Conditions